[Economic effectiveness of antirecurrence treatment of peptic ulcer].
D000328:Adult; D045930:Anabolic Agents / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008696:Methandrostenolone / Q000627:therapeutic use; D008875:Middle Aged; D010437:Peptic Ulcer / Q000188:drug therapy*; D012008:Recurrence; D014498:Uracil / Q000031:analogs & derivatives / Q000627:therapeutic use
D045930:Anabolic Agents; D014498:Uracil; D008696:Methandrostenolone
Ekonomicheskaia effektivnost' protivoretsidivnogo lecheniia bol'nykh iazvennoĭ bolezn'iu